Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants
Annals of Clinical and Translational Neurology · 2023
DOI: 10.1002/acn3.51731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2023. Verfasst von Daniel Natera-de Benito und 13 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, 08950, Spain. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Muscular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agència de Gestió d'Ajuts Universitaris i de Recerca, H2020 European Research Council, Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España.
Abstract (Originalsprache)
Objective
Mutations in ANXA11 cause amyotrophic lateral sclerosis (ALS) and have recently been identified as a cause of multisystem proteinopathy and adult‐onset muscular dystrophy. These conditions are adult‐onset diseases and result from the substitution of Aspartate 40 (Asp40) for an apolar residue in the intrinsically disordered domain (IDD) of ANXA11. Some ALS‐related variants are known to affect ANXA11 IDD; however, the mechanism by which the myopathy occurs is unknown.
Methods
Genetic analysis was performed using WES‐trio. For the study of variant pathogenicity, we used recombinant proteins, muscle biopsy, and fibroblasts.
Results
Here we describe an individual with severe and rapidly progressive childhood‐onset oculopharyngeal muscular dystrophy who carries a new ANXA11 variant at position Asp40 (p.Asp40Ile; c.118_119delGAinsAT). p.Asp40Ile is predicted to enhance the aggregation propensity of ANXA11 to a greater extent than other changes affecting this residue. In vitro studies using recombinant ANXA11 p.Asp40Ile showed abnormal phase separation and confirmed this variant is more aggregation‐prone than the ALS‐associated variant ANXA11 p.Asp40Gly . The study of the patient's fibroblasts revealed defects in stress granules dynamics and clearance, and muscle histopathology showed a myopathic pattern with ANXA11 protein aggregates. Super‐resolution imaging showed aggregates expressed as pearl strips or large complex structures in the sarcoplasm, and as layered subsarcolemmal chains probably reflecting ANXA11 multifunctionality.
Interpretation
We demonstrate common pathophysiology for disorders associated with ANXA11 Asp40 allelic variants. Clinical phenotypes may result from different deleterious impacts of variants upon ANXA11 stability against aggregation, and differential muscle or motor neuron dysfunction expressed as a temporal and tissue‐specific continuum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, 08950, Spain.
- Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, 08950, Spain.
- Laboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, 08950, Barcelona, Spain.
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08029, Spain.
- Department of Pathology, Hospital Sant Joan de Déu, Barcelona, 08950, Spain.
- Confocal Microscopy and Cellular Imaging Unit, Institut de Recerca Sant Joan de Déu, Barcelona, 08950, Spain.
ORCID-Profile: Janet Hoenicka
Förderung
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- H2020 European Research Council
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
- Ministerio de Ciencia e Innovación
Zitieren
APA
Natera-de Benito, D., Olival, J., Garcia-Cabau, C., Jou, C., Roldan, M., Codina, A., Expósito-Escudero, J., Batlle, C., Carrera-García, L., Ortez, C., Salvatella, X., Palau, F., Nascimento, A., & Hoenicka, J. (2023). Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51731
Vancouver
Natera-de Benito D, Olival J, Garcia-Cabau C, Jou C, Roldan M, Codina A, et al. Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants. Annals of Clinical and Translational Neurology. 2023. doi:10.1002/acn3.51731
BibTeX
@article{NateradeBenito2023,
author = {Natera-de Benito, Daniel and Olival, Jonathan and Garcia-Cabau, Carla and Jou, Cristina and Roldan, Mònica and Codina, Anna and Expósito-Escudero, Jessica and Batlle, Cristina and Carrera-García, Laura and Ortez, Carlos and Salvatella, Xavier and Palau, Francesc and Nascimento, Andrés and Hoenicka, Janet},
title = {Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants},
journal = {Annals of Clinical and Translational Neurology},
year = {2023},
doi = {10.1002/acn3.51731}
}
EUVIMED